MODTX — Modus Therapeutics Holding AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK45.64m
- SEK41.26m
Annual cashflow statement for Modus Therapeutics Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.02 | -20.7 | -18 | -16.4 | -15.8 |
| Changes in Working Capital | -1.21 | 4.61 | -3.72 | -0.283 | 1.16 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.23 | -16.1 | -21.7 | -16.7 | -14.7 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.05 | 0 | 0 | 0 |
| Purchase of Investments | |||||
| Cash from Investing Activities | 0 | -0.05 | 0 | 0 | 0 |
| Financing Cash Flow Items | 0 | -3.69 | 0 | -1.04 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.2 | 29.4 | 11.5 | 25.3 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.97 | 13.3 | -10.2 | 8.64 | -14.7 |